Education
About Us
Working with TipRanks
Follow Us
BioElectronics (BIEL)
:BIEL
BIEL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
BIEL FAQ
What was BioElectronics’s price range in the past 12 months?
Currently, no data Available
What is BioElectronics’s market cap?
BioElectronics’s market cap is $5.42M.
When is BioElectronics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioElectronics’s earnings last quarter?
Currently, no data Available
Is BioElectronics overvalued?
According to Wall Street analysts BioElectronics’s price is currently Overvalued.
Does BioElectronics pay dividends?
BioElectronics does not currently pay dividends.
What is BioElectronics’s EPS estimate?
BioElectronics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioElectronics have?
BioElectronics has 18,076,402,000 shares outstanding.
What happened to BioElectronics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioElectronics?
Currently, no hedge funds are holding shares in BIEL
---
Company Description
BioElectronics
BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. Its products include ActiPatch, Allay, Smart Insole, HealFast, and RecoveryRx. The company was founded by Andrew J. Whelan on April 10, 2000 and is headquartered in Frederick, MD.
---
---